Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-064558
Filing Date
2025-05-06
Accepted
2025-05-06 16:42:23
Documents
1
Period of Report
2025-05-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4046
  Complete submission text file 0000950170-25-064558.txt   5596
Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Reporting) CIK: 0001679076 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 25917946

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)